今日(2025年5月23日),中国医药巨头恒瑞医药正式登陆港交所,实现“A+H”两地上市。据悉,本次港股IPO,恒瑞发行价44.05港元,开盘后公司股价立刻大涨近3成。截至收盘,恒瑞港股市值3642亿港元,直接缔造2025年最大医药IPO。当我们提及恒瑞的故事,必定绕不开它背后的灵魂人物:孙飘扬。1982年,孙飘扬从中国药科大学化学制药专业毕业后,他便进入连云港制药厂(恒瑞医药前身)担任技术员。到...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.